Skip to library content
Back to the shelf
Peptide library
FDA-approvedSkin & aging

Afamelanotide

Also called Melanotan I, NDP-MSH

Evidence
Approved drug evidence
Class
MC1R agonist

Afamelanotide belongs to the MC1R agonist class. This library groups it under skin & aging. Its source category is FDA-approved.

Research libraryPeppy Care
Source snapshot
References9 linked sources

At a glance

Afamelanotide research overview
Compound classMC1R agonist
Associated brandsScenesse
Body systemSkin & aging
Use or research focusErythropoietic protoporphyria
Regulatory statusFDA-approved
Source evidence ratingApproved drug evidence

How does Afamelanotide work?

Stimulates eumelanin (photoprotection).

The source catalog maps this mechanism to Skin. A biological mechanism describes how a compound interacts with the body; it does not by itself prove a clinical benefit.

What does the evidence tell us?

This record is associated with evidence for an approved drug. Approval applies to a specific formulation and indication; it does not extend to every use, combination, or compounded preparation. Check the regulatory details and linked prescribing information.

Use the Citations tab to examine the underlying sources. Look for human studies, a relevant comparison group, meaningful outcomes, and adequate follow-up. An ingredient, approved drug, and compounded preparation may have different evidence.

Safety and considerations

An approved medicine can still have contraindications, interactions, and serious adverse effects. The current prescribing label is the place to check product-specific warnings. A clinician should review your medical history and other medicines before treatment.

This library is educational and does not provide dosing or treatment instructions. A listing here does not indicate that Peppy offers the compound.

Common questions

What is Afamelanotide?

Afamelanotide belongs to the MC1R agonist class. This library groups it under skin & aging. Its source category is FDA-approved. Its recorded use or research focus is: Erythropoietic protoporphyria.

Is Afamelanotide FDA-approved?

The catalog records: FDA-approved. Check the current product-specific regulatory information in the source links; a source category does not establish approval for every use or formulation.

How strong is the research?

This record is associated with evidence for an approved drug. Approval applies to a specific formulation and indication; it does not extend to every use, combination, or compounded preparation. Check the regulatory details and linked prescribing information.

Where can I read the research?

The Citations tab contains 9 reference links from the source dataset. The original research guide provides additional context. These links are a starting point for reading the evidence.

More for skin & aging

Factual catalog fields and citation links are adapted from Superpower’s Afamelanotide guide and the public dataset linked in the reference post. Peppy’s explanations are educational; this page does not represent an independent clinical review of every linked study.